• >
  • >
  • >
  • >
  • >
Upload Avatar (500 x 500)
Li Wang
Bioinformatics Science and Technology
Harbin Medical University
Heilongjiang
Language: Chinese, English
Contact
Tumor Heterogeneity Early Diagnosis Cancer Treatment Prognosis Big Data Ai Transcriptomics Molecular Mechanisms Immune Microenvironment Immunotherapy
Areas of Focus
  • Malignant tumor heterogeneity analysis
  • Early diagnosis
  • Cancer treatment decision-making
  • Prognosis evaluation
  • Biomedical big data
  • Artificial intelligence
  • Single-cell and spatial transcriptomics
  • Cancer evolution molecular mechanisms
  • Tumor immune microenvironment
  • Immunotherapy
Publications
  • LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases., Li Wang, 2023
  • Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes., Li Wang, 2021
  • LncTarD: a manually-curated database of experimentally-supported functional lncRNA-target regulations in human diseases., Li Wang, 2020
  • The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis., Li Wang, 2022
  • Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers., Li Wang, 2019
  • Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines., Li Wang, 2020
  • Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer., Li Wang, 2023
  • Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer., Li Wang, 2023
  • Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data., Li Wang, 2022
  • Comprehensive identification and potential application of genetic alteration-driven enhancer RNAs for eRNA-targeted therapy in breast cancer., Li Wang, 2023
  • Genome-wide DNA methylome analysis reveals a critical role of methylation-dysregulated lncRNAs in autophagy regulation in glioblastoma., Li Wang, 2023
  • Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer., Li Wang, 2024
Awards
  • Heilongjiang Province High-level Talent
  • Heilongjiang Province Excellent Youth
  • Heilongjiang Province Innovative Talent
  • University-level Outstanding Scientific Research Worker
  • Top Ten Youth Post Expert
  • Excellent Teacher
  • May Fourth Youth Medal
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that AGP may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from AGP.
Submit

Thank you for your message!
We will contact you soon.